As China and the U.S. presently duke it out over biopharma innovation supremacy, a clutch of Europe’s biggest drugmakers are calling on the bloc to not lose sight of its R&D roots. | As China and the ...
Eric Dube, Ph.D., the CEO who rebranded Travere Therapeutics and oversaw the launch of its rare kidney disease drug Filspari, will ...
"These Phase 3 results build on the established efficacy of Caplyta in bipolar depression and represent an important step in evaluating its potential to address both depressive and acute manic ...
The White House is threatening yet another change to the childhood vaccine schedule in line with Secretary of Health and Human Services secretary Robert F. Kennedy Jr.’s MAHA agenda. | The president ...
Bayer has decided to offload its aging cancer drug Stivarga to German compatriot Grünenthal as competition mounts. | Bayer has decided to offload its aging cancer drug Stivarga to German compatriot ...
Novo CEO Mike Doustdar faced a tough crowd as the Danish pharma gathered investors in London this morning for the compan | With reports leaking out of investor discontent, CEO Mike Doustdar opened ...
Public Citizen stressed that it supports efforts to lower drug costs for people in America, while caveating that the MFN deals as understood—and with added color from companies on the policy’s ...
IntraBio is on a roll with its expansion plans for chemically altered amino acid, Aqneursa. | IntraBio's streak of success in the rare neurological category continues, as the drugmaker racks up a ...
Eli Lilly is sharpening its competitive edge in the crowded oral SERD arena as the FDA has approved a combination of its ...
In their lawsuit, BMS and Ono accuse Amgen of aiming to market its biosimilar ahead of the expiration of key U.S. patents ...
Much like GSK (formerly GlaxoSmithKline) and the once Sanofi-Aventis (now just Sanofi), Novo Nordisk is slimming down its ...
Novo CEO Mike Doustdar—tapped to breathe new life into the Danish drugmaker last year after losing GLP-1 marketing ground to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results